Evgen to investigate new SFX-01 tablet formulation
The therapy has the potential to treat neurological and oncological conditions
Read More
Author: John Pinching
Research provides hope for patients with neurodegenerative disease
Findings highlight a potential new drug candidate that may delay disease progression
Read More
Sequana announces results from study of direct sodium removal
All ten patients involved in the research effectively and rapidly eliminated persistent congestion
Read More
Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients
Procedure is carried out following the completion of surgery to remove all visible disease
Read More
Lindis biotech presents encouraging data from bladder cancer trial
Data revealed that 100% of patients achieved a complete remission with no recurrence
Read More- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
